You are here

Program Directors

Program Directors oversee the research activities in one or more parts of the Institute's research funding program, managing a portfolio of grants and contracts and coordinating program efforts in these specifically defined areas of neuroscience research. Please reach out to individual Program Directors for more information about specific opportunities.

Bioengineering
Brain and Spinal Cord Injury
Brain Cancer
Channels, Synapses, and Circuits
CNS Infection/Neurovirology
Cognitive Neuroscience
Computational Neuroscience
Epidemiology/Biostatistics
Epilepsy & Epileptogenesis
Genetic and Developmental Research
Lysosomal Storage Disorders
Movement Disorders
Multiple Sclerosis
NeuroAIDS
Neurodegeneration
Neuroprotection
Pain
Pediatric Neurology
Programs to Enhance Neuroscience Workforce Diversity (OPEN-WD)
Regeneration
Rehabilitation
Stem Cells
Stroke
Systems Neuroscience
Translational Research

Bioengineering

Jim Gnadt – Sensory systems, neuroendocrine, computational neuroscience, prosthetics
Nick Langhals – Neural engineering with emphases in neuroprostheses, neuromodulation, brain-computer interface (BCI) devices, prosthetic control, and neural interface technology development
Daofen Chen – Motor systems, neuroprosthetic and robotic applications, rehab engineering

Brain and Spinal Cord Injury

Patrick Bellgowan – Basic, translational and clinical studies of traumatic brain injury
Scott Janis – Clinical trials in traumatic brain injury
Lyn Jakeman – Spinal Cord Injury
Daofen Chen – clinical studies and behavioral interventions for stroke and cerebral palsy, rehabilitation
Francesca Bosetti
Jim Koenig

Brain Cancer

Channels, Synapses and Circuits

Miriam Leenders - Basic structure and function of channels, structural biology, preteomics
Daniel Miller – Invertebrate NMJ synaptic development, structure and function
Shai Silberberg – Channels, transporters and pumps, channelopathy
Ned Talley – Synaptic transmission, plasticity, structure, development and regeneration
Vicky Whittemore - Seizure prediction

CNS Infection/Neurovirology

May Wong – infectious disease, neurovirology, prion diseases

Cognitive Neuroscience

Deb Babcock – Behavioral and cognitive neuroscience, neuroimaging, CNS plasticity
Patrick Bellgowan – Cognitive/emotional domains affected by TBI
Claudia Moy – Epidemiology and clinical studies in cognition
Daofen Chen – Sensorimotor learning and executive functions

Computational Neuroscience

Jim Gnadt – Sensory systems, neuroendocrine systems, thalamo-cortical functions, computational neuroscience, prosthetics control systems

Epidemiology/Biostatistics

Peter Gilbert – Biostatistics and clinical trial design
Claudia Moy – Clinical trial design, quality of life and other patient-reported outcome measures

Epilepsy & Epileptogenesis

Vicky Whittemore – Animal models of epilepsies; SUDEP
Adam Hartman – Pediatric Epilepsy

Genetic and Developmental Research

Laura Mamounas – signal transduction in development and plasticity, autism spectrum disorders, Fragile X, Rett Syndrome, tuberous sclerosis complex
Jill Morris – Mid-/hind-brain development/malformations, hydrocephalus, Spina Bifida, Tourette syndrome
Glen Nuckolls – Muscular dystrophies, spinal muscular atrophy, inherited neuropathies
Robert Riddle – Developmental neuroscience, Down Syndrome
Tim Lavaute – Neurogenesis and progenitor cell biology in nervous system development and function

Lysosomal Storage Disorders

Jill Morris

Movement Disorders

Multiple Sclerosis

Ursula Utz – Multiple Sclerosis

NeuroAIDS

May Wong – NeuroAIDS

Neurodegeneration

Deb Babcock – Lewy Body Dementia (LBD)
Robin Conwit – Amyotrophic Lateral Sclerosis (ALS) clinical trials
Roderick Corriveau – Alzheimer’s disease (AD), vascular contributions to cognitive impariment and dementia (VICD) including vascular cognitive impairment (VCI) and vascular dementia (VaD), CADASIL, basic research related to neurodegeneration in the areas of protein folding, protein trafficking, cytoskeleton, synapses, and synaptic receptors
Amelie Gubitz – Amyotrophic Lateral Sclerosis (ALS), spinal and bulbar muscular atrophy, hereditary spastic paraplegia, Friedreich’s ataxia
Codrin Lungu – Parkinson’s disease and movement disorders
Daniel Miller – Huntington’s disease, neuromuscular junction, spinocerebellar ataxia
Beth-Anne Sieber – Parkinson’s disease (molecular genetics, DBS)
Margaret Sutherland – Parkinson’s disease, Frontotemporal dementia

Neuroprotection

Francesca Bosetti – ischemic stroke
Jim Koenig – Hemorrhagic stroke, neonatal/pediatric hypoxia/ischemia, global cerebral ischemia

Pain

Michael L. Oshinsky – Pain, pain management, neuroimaging, perception

Pediatric Neurology

Adam Hartman – Pediatric clinical trials
Jim Koenig – cerebral palsy and perinatal stroke
Daofen Chen – Clinical studies in cerebral palsy and childhood movement disorders

Programs to Enhance Neuroscience Workforce Diversity (OPEN-WD)

Michelle Jones-London – Chief, Office of Programs to Enhance Neuroscience Workforce Diversity
Edgardo Falcon-Morales – Diversity F31, Research Supplements to Support Diversity and Re-entry in Biomedical Research, SCORE (SC1 and SC2) awards, ENDURE and Diversity R25 awards
Lauren Ullrich – Diversity K22, Diversity Faculty K01, D-SPAN F99/K00, Summer R25s

Regeneration

Lyn Jakeman – Rehabilitation and combination therapies, spinal cord injury
Nick Langhals – Engineering interfaces and devices
Timothy Lavaute – Adult neurogenesis, brain regenerative repair

Rehabilitation

Daofen Chen – Sensorimotor functions, rehabilitation, systems-based technology
Lyn Jakeman – Rehabilitation and combination therapies, spinal cord injury
Scott Janis – Clinical trials, Stroke Trials Network

Stem Cells

Timothy Lavaute – Stem and progenitor cell biology in nervous system development and function, application/treatment, tissue engineering

Stroke

Francesca Bosetti – Ischemic stroke, neuronal mechanisms, functional recovery, blood brain barrier
Scott Janis – Clinical trials and epidemiology, cerebrovascular disease, NINDS Stroke Trials Network and the Neurological Emergencies Treatment Trials Network (NETT)
Jim Koenig – Hemorrhagic stroke, brain vascular malformations, brain responses to cardiovascular events, sex differences in stroke, aneurysm, pediatric stroke and blood flow
Claudia Moy – Clinical trials and epidemiology studies, aneurysm, AVMs
Daofen Chen – Clinical studies of sensorimotor learning and interventions in post-stroke and cerebral palsy
Roderick Corriveau – Vascular contributions to cognitive impairment and dementia (VCID), including vascular cognitive impairment and vascular dementia

Systems Neuroscience

Jim Gnadt – Sensory systems, neuroendocrine, computational neuroscience, prosthetics
Janet He – Sleep, circadian rhythms, feeding and body weight, sleep in neurological disorders, neurobiology of obesity and sleep disordered breathing
Daofen Chen – Motor systems, basic and clinical studies of cortical and subcortical systems neurophysiology

Translational Research

Stephanie Fertig – Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs, Cooperative Research to Enable and Advance Translational Enterprises: Therapeutic Devices Small Business Programs (SBIR/STTR), Translational Devices
Mohamed Hachicha – Blueprint Neurotherapeutic Network (BPN), preclinical neurotherapeutic small molecule development
John Kehne – Epilepsy Therapy Screening Program (ETSP), preclinical pharmacology, animal models. preclinical neurotherapeutic development
Brian Klein – Epilepsy Therapy Screening Program (ETSP), preclinical pharmacology, animal models. preclinical neurotherapeutic development
Pascal Laeng – Blueprint Neurotherapeutic Network (BPN), preclinical neurotherapeutic small molecule development, high throughput screening
Linda McGavern – Cooperative Research to Enable and Advance Translational Enterprises (CREATE), preclinical neurotherapeutic biologics development
Mary Ann Pelleymounter – Innovation Grants to Nurture Initial Translational Efforts (IGNITE), Blueprint Neurotherapeutic Network (BPN), preclinical pharmacology, animal models, systems biology, pharmacodynamic markers, preclinical neurotherapeutic development
Shamsi Raeissi – Epilepsy Therapy Screening Program (ETSP), preclinical pharmacology, animal models. preclinical neurotherapeutic development
David Jett – NIH Counterterrorism (CounterACT) program, neurotoxicology
David Yeung – NIH Counterterrorism (CounterACT) R21 and U01 translational research grants
Chris Boshoff – Cooperative Research to enable and Advance Translational Enterprises (CREATE), preclinical neurotherapeutic biologics development

Date last modified: Wed, 2018-12-12 17:16